WHO ICTRP trial

A prospective study to evaluate the effect of midazolam before surgery on…

KCT0002692 · Clinical Research Information Service (CRIS) · Not Recruiting

Key facts

Trial ID KCT0002692
Public title A prospective study to evaluate the effect of midazolam before surgery on nausea, vomiting prevention and anesthesia recovery time in gynecologic day surgery
Scientific title The effect of midazolam on postoperative nausea, vomiting prevention and anesthesia recovery time in gynecological outpatients
Primary sponsor Keimyung University Dongsan Medical Center
Registry Clinical Research Information Service (CRIS)
Recruitment status Not Recruiting
Study type Interventional Study
Phase Not applicable
Countries Korea, Republic of
Conditions Not Applicable
Interventions Drug : Before surgery, the patients are divided into two groups: midazolam 50 mcg / kg intravenously and normal saline only intravenously.
Registration date Feb 14, 2018
Target size 50
Registry page cris.nih.go.kr

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations